Hypersomnia as a predictor of response to intravenous ketamine/intranasal esketamine in treatment resistant depression

This publication has 16 references indexed in Scilit:

• The effects of ketamine on typical and atypical depressive symptoms
  Acta Psychiatrica Scandinavica, 2020
• Sleep, insomnia, and depression
  Neuropsychopharmacology, 2019
• Depression and Sleep
  International Journal of Molecular Sciences, 2019
• Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders
  Journal of Affective Disorders, 2018
• Mechanisms of ketamine action as an antidepressant
  Molecular Psychiatry, 2018
• Motor-Activity Markers of Circadian Timekeeping Are Related to Ketamine’s Rapid Antidepressant Properties
  Biological Psychiatry, 2017
• The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Trial: A Review
  The Canadian Journal of Psychiatry, 2010
• Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report
  Psychological Medicine, 2009
• The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
  Biological Psychiatry, 2003
• Sleep Research in Affective Illness: State of the Art Circa 1987
  SLEEP, 1987